Malta - English - Medicines Authority

accord healthcare limited - ondansetron - solution for injection - ondansetron 2 mg/ml - antiemetics and antinauseants

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - mitoxantrone - concentrate for solution for infusion - 2 milligram(s)/millilitre - anthracyclines and related substances; mitoxantrone

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - daunorubicin hydrochloride, quantity: 2.14 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - daunorubicin is an anthracycline, antineoplastic agent used as a standard component of various regimes for the treatment of leukemia. disseminated tumors - daunorubicin has been investigated for use in these tumors and has found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

jazz pharmaceuticals anz pty ltd - daunorubicin, quantity: 44 mg; cytarabine, quantity: 100 mg - injection, powder for - excipient ingredients: cholesterol; sucrose; distearoylphosphatidylglycerol; trolamine; copper gluconate; distearoylphosphatidylcholine - vyxeos is indicated for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-aml) or aml with myelodysplasia-related changes (aml-mrc)

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

remedy pharma - daunorubicina (clorhidrato) - daunorubicina (clorhidrato)....20 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - epirubicin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - epirubicin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - epirubicin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - epirubicin hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - epirubicin hydrochloride 2 mg/ml;   - solution for injection - 2 mg/ml - active: epirubicin hydrochloride 2 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of: · breast cancer, · gastric cancer, · ovarian cancer, · small cell lung cancer, · lymphoma (non-hodgkin's lymphoma), · advanced/metastatic soft tissue sarcoma, and · superficial bladder cancer (tis; ta). in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3). epirubicin has also shown antitumour activity in the following tumours: · carcinoma of the oesophagus · primary hepatocellular carcinoma · pancreatic carcinoma · carcinoma of the head and neck · acute leukaemias and multiple myeloma